Proteus Mirabilis

Download as pdf or txt
Download as pdf or txt
You are on page 1of 6

See discussions, stats, and author profiles for this publication at: https://www.researchgate.

net/publication/347464724

Proteus Mirabilis Virulence Factors: Review

Article · March 2021


DOI: 10.31838/ijpr/2021.13.01.169

CITATIONS READS

0 846

4 authors, including:

Thualfakar Hayder Hasan Abusaiba Kasim Alasedi


Altoosi University College Altoosi University College
32 PUBLICATIONS   79 CITATIONS    29 PUBLICATIONS   23 CITATIONS   

SEE PROFILE SEE PROFILE

Ahmed Aljanaby
University Of Kufa
63 PUBLICATIONS   443 CITATIONS   

SEE PROFILE

Some of the authors of this publication are also working on these related projects:

Master degree View project

microbiology View project

All content following this page was uploaded by Ahmed Aljanaby on 03 January 2021.

The user has requested enhancement of the downloaded file.


ISSN 0975-2366
DOI:https://doi.org/10.31838/ijpr/2021.13.01.169
Review Article

Proteus Mirabilis Virulence Factors: Review


THUALFAKAR HAYDER HASAN1, KASIM KADHIM ALASEDI2, AHMED ABDULJABBAR JALOOB
ALJANABY3
1
Department of Medical Laboratories Techniques; Altoosi University College, Najaf, Iraq
2
Department of Nursing; Altoosi University College, Najaf, Iraq
3
Department of Biology, Faculty of Science, University of Kufa, Iraq
*Corresponding Author
Email ID: [email protected], [email protected], [email protected]
Received: 26.10.20, Revised: 15.11.20, Accepted: 13.12.20

ABSTRACT
A common cause of the urinary tract is Proteus mirabilis. This microorganism has many factors of virulence.
Proteus mirabilis may express adhesins, flagella, toxins, enzymes, quorum sensing, and factors for immune
avoidance. This pathogen is determined as an opportunistic pathogen responsible for many infections like
urinary tract infections (UTIs) and nosocomial infections in immunocompromised patients and who suffer from
various diseases.
Keywords: Swarming; UTIs; Virulence Factors; Immune System

INTRODUCTION It's also identified as Proteus UTI based upon the


The Proteus spp. are part of Enterobacteriaceae, nature and condition of patients as it is
these bacteria are gram-negative rods that reside challenging to handle, or sometimes lethal
under aerobics or anaerobic circumstances, it infection Infection risks are evident in patients with
motile with peritrichous flagella that characterized catheters and non-catheters, including urolithiasis
by the swarming phenomenon (Schaffer and formation, obstruction of the urinary tract, urinary
Pearson,2017). tract infection, stones of the bladder, and kidneys
Many species were belonging to Proteus, one of and bacteriuria (Hasan and Al-Harmoosh,2020).
the most important species is Proteus mirabilis, In kidneys, the infection of Proteus mirabilis is
this pathogen is determined as an opportunistic characterized as severe histological damage
pathogen responsible for many infections like resulting in acute pyelonephritis as well as in
urinary tract infections (UTIs) and nosocomial males than females (Hayder and Aljanaby,
infections in immunocompromised patients and 2019a). Many reports also have shown that the
who suffer from various diseases (Qiao et rates of Proteus mirabilis immunoglobulin M (IgM)
al.,2019). from sera of patients with scientifically
These bacteria are environmental widespread in documented rheumatoid arthritis were high
water pollution, soil, and others due to (Hayder and Aljanaby, 2019b). Rheumatoid
decomposer ability to organic materials.The role patients' sera contain more Proteus mirabilis IgM
of Proteus mirabilis in UTIs is divided into two antibodies than the others (Kadhum and Hasan,
parts, hematogenous infection and ascending 2019). In those sera, substantially higher IgA
infections, where these bacteria colonize the parts were found in Proteus mirabilis antibodies and
of the urinary system one after another starting studies were also shown in all 11 different
from the urethra and ending with the kidney serotypes of the tested Proteus mirabilis and
(Rózalski et al.,1997). The second type of Proteus Proteus spp to be associated with IgM response in
mirabilis infection is more common in patients rheumatoid arthritis patients (Ebringer et
with urinary catheters or structural defects and al.,2006; Majeed et al.,2020).
after the urinary tract surgery, this last type is most
common in UTIs (Jacobsen et al.,2008). Proteus VIRULENCE FACTORS
mirabilis is the most common cause of 1. Adhesins
complicated urinary tract infection after Proteus mirabilis 's bacterial adhesion is a key
Escherichia coli and Klebsiella pneumonia and step in colonizing and developing infections,
one of the most common cause of bacterial which is done by fimbriae (Hasan,2020). There
infections associated with catheters in the long- are five common fimbriae type that implicated in
standing catheter group of patients (Hasan et infection as following:
al.,2020).

2145| International Journal of Pharmaceutical Research | Jan - Mar 2021 | Vol 13 | Issue 1
Thualfakar Hayder Hasan et al / Proteus Mirabilis Virulence Factors: Review

A. Mannose-resistant / Proteus-like (MR/P) 2. Motility


fimbriae: The motility is the most important virulence factor
This kind of fimbria is the most appropriate form in Proteus mirabilis that influence in invading and
in Proteus mirabilis, constructed along the spreading of infection in urinary tract parts (Kuan
pathway of the chaperone – usher. The cluster et al.2014). The infection begins with the invasion
gene MR / P consists of mrpABCDEFGHJ and of the periurethral region, then it travels through
mrpl (Aljanaby and Aljanaby,2018). The main the urethra and progresses to the bladder, other
fimbrial structural subunit codes for mrpA, the areas of the urinary tract (Hickling et al.,2017).
smaller subunits for mrPBEFG, the chaperone Motility strongly promotes interaction with these
encoding of mrpD, mrpC for usher, mrpH sites (Batirel et al.,2020). Proteus mirabilis is a
encoding fimbria pilin, and the protein for mrpJ flagellar peritrichous bacterium (Fattorini et
encoding repressive flagellar regulon al.,2020). The motility of this microorganism is
transcription. mrpI encodes the invertible portion swarming, when this microorganism is swarming,
of the recombinase from ON to OFF (mrp operon the expression of virulence is increased (Kotian et
transcription) or from OFF to ON stopping mrp al.,2020).
operon transcriptions. Pyelonephritis was
consistent with the development of this fimbriae 3. Toxins and Enzymes
(Majeed and Aljanaby,2019). A. Hemolysin:
B. Uroepithelial cell adhesion (UCA/NAF) Hemolysin is a toxin that enters the target
fimbriae: membrane of the eukaryotic cell and causes
This type of fimbriae is taking the form of long pores that trigger ion efflux and then cell
flexible rods, the UCA/NAF fimbriae have an disruption (Cabezas et al.,2017). Hemolysin
essential adhesion role to the uroepithelial cells promotes bacterial infection spread in the kidney
also it has an important role in the colonization of and pyelonephritis develops in ascending UTIs
the urinary tract (Jiang et al.,2018). The genes of (Los et al.,2013). Proteus mirabilis hemolysin
the HI43201 genome sequence called PMI0532- genes are a two-part secretion (hpmA and hpmB)
PMI0536 are found in this uca operon (Chahales (Dal Peraro and Van Der Goot,2016). HpmB
and Thanassi,2017). holds HpmA and activates it, while HpmA is
C. Ambient-temperature fimbriae (ATF): observed to be placed beyond membranes that
In the ambient way of Proteus mirabilis, the ATF take part in the HpmA secretion cycle in the
fimbriae are important (Hasan, 2020b). The periplasm. HpmA exhibits cytotoxic effect on
optimal expression of these fimbriae is only at 23 proximal tubular epithelial cells produced in the
° C (Roh et al.,2010). These fimbriae in the human renal (Etxaniz et al.,2020). There is no
Proteus mirabilis colonization host are not difference that can occur in colonization between
important for the ATF mutant strain and wild the wild type strain and the hpmA mutant Proteus
strain involving urinary tract infection (Simms and mirabilis infection (Hertle,2005). This Hemolysin
Mobley,2008). is presumably not as present during in vivo
D. Proteus mirabilis fimbriae (PMF): infection or hides its contribution because of the
The PMF fimbriae are genetically organizing by presence of certain virulence factors (Ostolaza et
five functional genes pmfACDEF (Bode et al.,2019).
al.,2016). The role of PMF fimbriae that shown is B. Proteus toxic agglutinin (Pta):
in old studies is introducing in the bacterial cells Proteus toxic agglutinin is a protein that is
colonizing of urinary tract lower part but not the designated as the outer membrane
kidneys, recently, the studies proved that the role autotransporter that mediates aggregation of the
of PMF fimbriae is vital in the colonization of cell and includes the catalytic α-domain that can
bacterial cells to bladder and kidneys (Sarshar et lyse the kidney and bladder cells (Gupta et
al.,2020). al.,2019). The Proteus mirabilis negative pta gene
E. Proteus mirabilis P-like pili (PMP) fimbriae: had reduced pathology, as well as a serious
PMP fimbriae were first identified from a dog with colonization defect in urine, kidneys, and spleen
urinary infection by Proteus mirabilis strain (Engel et al.,2007).
(Debnath et al.,2018). The human Proteus C. Urease:
mirabilis uropathogenic strain HI4320 includes Urease is significant in Proteus mirabilis
PMP (Sun et al.,2019). There are nine genes pathogenesis, which catalyzes stones formation in
(PMI2216-PMI2224) of the human operon the kidney and bladder or inhibits the urinary
structure (Baldo and Rocha,2014). Additional tract (Flannery et al.,2009). Urease is extremely
studies are required to confirm PMP fimbriae 's important for Proteus mirabilis pathogenesis
participation in Proteus mirabilis pathogenesis (Ranjbar et al.,2015). This enzyme catalyzes the
(Tsai et al.,2017). formation of stones in the kidney and bladder or

2146| International Journal of Pharmaceutical Research | Jan - Mar 2021 | Vol 13 | Issue 1
Thualfakar Hayder Hasan et al / Proteus Mirabilis Virulence Factors: Review

encrusts or obstructs the urinary tract (Armbruster CONFLICT OF INTEREST


et al.,2017). The cluster of urease genes None to declare
(ureRDABCEFG) codifies the multimeric nickel-
metalloenzyme, which hydrolyzes urea into CONSENT OF ETHICS
ammonia and dioxide, increases the PH, and All data was approved and carried out in
induces multipurpose urinary ions precipitation accordance with approved guidelines
that leads to stone formation (Alamuri et
al.,2009). This pH modification is essential during REFERENCES
colonization of the Proteus mirabilis catheter, 1. Alamuri, P., Eaton, K. A., Himpsl, S. D., Smith, S.
facilitating bacterial adhesion and the N., & Mobley, H. L. (2009). Vaccination with
development of biofilm incrustation (Carlini and proteus toxic agglutinin, a hemolysin-
independent cytotoxin in vivo, protects against
Polacco,2008). Stone forming is a characteristic
Proteus mirabilis urinary tract infection. Infection
of infection with Proteus mirabilis, which contains
and immunity, 77(2), 632-641.
a variety of advantages like evade of the host
2. Aljanaby, A. A. J., and Aljanaby, I. A. J. (2018).
immune system, ureter blockage, ammonia
Prevalence of aerobic pathogenic bacteria
exposure to the host cells, and clear harm to isolated from patients with burn infection and
tissues (Konieczna et al.,2012). Such findings their antimicrobial susceptibility patterns in Al-
refer to a niche for the microorganism which is Najaf City, Iraq-a three-year cross-sectional
defensive and abundant in nutrients study. F1000Research, 7(1157), 1157.
(Rutherford,2014). 3. Arciola, C. R., Campoccia, D., & Montanaro, L.
(2018). Implant infections: adhesion, biofilm
4. Quorum sensing formation and immune evasion. Nature Reviews
Several types of bacteria use cell-cell contact to Microbiology, 16(7), 397.
sense population density and organize gene 4. Armbruster, C. E., Smith, S. N., Johnson, A. O.,
expression (Stankowska et al.,2012). Proteus DeOrnellas, V., Eaton, K. A., Yep, A., ... &
mirabilis has a luxS homolog, which develops AI- Mobley, H. L. (2017). The pathogenic potential of
2 (Younis et al.,2016). This quorum sensing Proteus mirabilis is enhanced by other
system does not impact swimming or swarming uropathogens during polymicrobial urinary tract
motility, swarming cell differentiation, or the in infection. Infection and immunity, 85(2).
vitro test of virulence (Wang et al.,2006). Though, 5. Baldo, C., & Rocha, S. P. D. (2014). Virulence
in species using this signaling molecule, AI-2 factors of Uropathogenic Proteus Mirabilis-a mini
produced by Proteus mirabilis can influence gene review. Int. J. Technol. Enhanc. Emerg. Eng.
expression (Schneider et al.,2002). Res, 3, 24-27.
6. Batirel, A., Regmi, S. K., Singh, P., Mert, A.,
5. Immune Evasion Konety, B. R., & Kumar, R. (2020). Urological
The presence of bacteria in the host will prevent infections in the developing world: an increasing
innate and adaptive immune reactions problem in developed countries. World Journal
(Norsworthy and Pearson,2017). Proteus mirabilis of Urology, 1-11.
has multiple modes of evasion (Belas et al.,2004). 7. Belas, R., Manos, J., & Suvanasuthi, R. (2004).
Proteus mirabilis encodes a metalloproteinase Proteus mirabilis ZapA metalloprotease degrades
(ZapA), that cleaves serum and secretory a broad spectrum of substrates, including
antimicrobial peptides. Infection and
immuno-globulin A1 (IgA1), IgA2, and IgG (Liu et
immunity, 72(9), 5159-5167.
al.,2015). ZapA mutation leads to a drastic
8. Bode, N. J., Chan, K. W., Kong, X. P., & Pearson,
reduction in the recovery of urine bacteria,
M. M. (2016). Distinct residues contribute to
bladder, and renal bacteria (Arciola et al.,2018).
motility repression and autoregulation in the
It can vary the MR / P and flagellin expression, Proteus mirabilis fimbria-associated
thereby tricking the immune system (Zhang et transcriptional regulator AtfJ. Journal of
al.,2015). As mentioned earlier, Proteus bacteriology, 198(15), 2100-2112.
mirabilis's uropathogenesis is typical of the stone 9. Cabezas, S., Ho, S., Ros, U., Lanio, M. E., Alvarez,
formation (Fusco et al.,2017). This event helps to C., & Van Der Goot, F. G. (2017). Damage of
retain the urine, create a bacterial reservoir, avoid eukaryotic cells by the pore-forming toxin
the wash-out, and evasion of the immune system sticholysin II: consequences of the potassium
(Habibi et al.,2015). efflux. Biochimica et Biophysica Acta (BBA)-
Biomembranes, 1859(5), 982-992.
FINANCIAL SUPPORT 10. Carlini, C. R., & Polacco, J. C. (2008). Toxic
This research did not receive any specific grant properties of urease. Crop Science, 48(5), 1665-
from funding agencies in the public, commercial, 1672.
or not-for-profit sectors.

2147| International Journal of Pharmaceutical Research | Jan - Mar 2021 | Vol 13 | Issue 1
Thualfakar Hayder Hasan et al / Proteus Mirabilis Virulence Factors: Review

11. Chahales, P., & Thanassi, D. G. (2017). Structure, Sys Rev Pharm 2020; 11(6): 817-823. DOI:
function, and assembly of adhesive organelles by 10.31838/srp.2020.6.118.
uropathogenic bacteria. Urinary Tract Infections: 23. Hasan, T. H. (2020a). Extended Spectrum Beta
Molecular Pathogenesis and Clinical Management, Lactamase E. Coli isolated from UTI Patients in
277-329. Najaf Province, Iraq. International Journal of
12. Dal Peraro, M., & Van Der Goot, F. G. (2016). Pharmaceutical Research,2020. 12.4.673-677.
Pore-forming toxins: ancient, but never really out 24. Hasan, T. H. (2020b). Extended Spectrum Beta-
of fashion. Nature reviews microbiology, 14(2), Lactamase Producing Klebsiella Pneumonia
77-92. Isolated from Patients with Urinary Tract
13. Debnath, I., Stringer, A. M., Smith, S. N., Bae, E., Infection in Al-Najaf Governorate – Iraq.
Mobley, H. L., Wade, J. T., & Pearson, M. M. International Journal of Advances in Science,
(2018). MrpJ directly regulates proteus mirabilis Engineering and Technology(IJASEAT),8(1),13-16.
virulence factors, including fimbriae and type VI 25. Hasan, T.H., Al-Harmoosh, R.A., Al-Khilkhali,
secretion, during urinary tract infection. Infection H.J.B.(2020). Identification of HIV virus in najaf
and immunity, 86(10). city, Iraq. International Journal of Research in
14. Ebringer, A., Rashid, T., Wilson, C., Ptaszynska, Pharmaceutical Sciences, 2020, 11(3), pp. 4866-
T., & Fielder, M. (2006). Ankylosing Spondylitis, 4871.
HLA-B27 and Klebsiella-an overview: proposal 26. Hayder, T., & Aljanaby, A. A. J. J. (2019a).
for early diagnosis and treatment. Current Antibiotics susceptibility patterns of Citrobacter
Rheumatology Reviews, 2(1), 55-68. freundii isolated from pa-tients with urinary tract
15. Engel, P., Brandt, K. K., Rasmussen, L. H., infection in Al-Najaf governorate– Iraq.
Ovesen, R. G., & Sørensen, J. (2007). Microbial International Journal of Research in
degradation and impact of Bracken toxin Pharmaceutical Sciences, 10(2), 1481-1488
ptaquiloside on microbial communities in 27. Hayder, T., & Aljanaby, A. A. J.(2019b).
soil. Chemosphere, 67(1), 202-209. Genotypic Characterization of Antimicrobial
16. Etxaniz, A., González‐Bullón, D., Martín, C., Resistance-Associated Genes in Citrobacter
Alonso, M. T., & Ostolaza, H. (2020). Irreversible Freundii Isolated from Patients with Urinary
versus repairable membrane poration: Tract Infection in Al-Najaf GovernorateIraq.
differences in permeabilization elicited by OnLine Journal of Biological Sciences, 19(2),
Bordetella Adenylate Cyclase Toxin and its 132–145.
hemolysin domain in macrophages. The FEBS 28. Hertle, R. (2005). The family of Serratia type
Journal, 287(9), 1798-1815. pore forming toxins. Current Protein and
17. Fattorini, C., Lopez-Beltran, A., & Raspollini, M. Peptide Science, 6(4), 313-325.
R. (2020). Urothelial Carcinoma, Sarcomatoid 29. Hickling, D. R., Sun, T. T., & Wu, X. R. (2017).
Type. Uropathology, 491-493. Anatomy and physiology of the urinary tract:
18. Flannery, E. L., Mody, L., & Mobley, H. L. (2009). relation to host defense and microbial
Identification of a modular pathogenicity island infection. Urinary Tract Infections: Molecular
that is widespread among urease-producing Pathogenesis and Clinical Management, 1-25.
uropathogens and shares features with a diverse 30. Jacobsen, S. M., Stickler, D. J., Mobley, H. L. T., &
group of mobile elements. Infection and Shirtliff, M. E. (2008). Complicated catheter-
immunity, 77(11), 4887-4894. associated urinary tract infections due to
19. Fusco, A., Coretti, L., Savio, V., Buommino, E., Escherichia coli and Proteus mirabilis. Clinical
Lembo, F., & Donnarumma, G. (2017). Biofilm microbiology reviews, 21(1), 26-59.
formation and immunomodulatory activity of 31. Jiang, W., Ubhayasekera, W., Pearson, M. M., &
Proteus mirabilis clinically isolated Knight, S. D. (2018). Structures of two fimbrial
strains. International journal of molecular adhesins, AtfE and UcaD, from the uropathogen
sciences, 18(2), 414. Proteus mirabilis. Acta Crystallographica Section
20. Gupta, A., Mumtaz, S., Li, C. H., Hussain, I., & D: Structural Biology, 74(11), 1053-1062.
Rotello, V. M. (2019). Combatting antibiotic- 32. Kadhum, H. A., & Hasan, T. H. (2019). The Study
resistant bacteria using nanomaterials. Chemical of Bacillus Subtils Antimicrobial Activity on Some
Society Reviews, 48(2), 415-427. of the Pathological Isolates. International Journal
21. Habibi, M., Karam, M. R. A., Shokrgozar, M. A., of Drug Delivery Technology 2019; 9(2); 193-
Oloomi, M., Jafari, A., & Bouzari, S. (2015). 196. https://doi.org/10.25258/ijddt.9.2.12.
Intranasal immunization with fusion protein 33. Konieczna, I., Zarnowiec, P., Kwinkowski, M.,
MrpH· FimH and MPL adjuvant confers Kolesinska, B., Fraczyk, J., Kaminski, Z., & Kaca,
protection against urinary tract infections caused W. (2012). Bacterial urease and its role in long-
by uropathogenic Escherichia coli and Proteus lasting human diseases. Current Protein and
mirabilis. Molecular immunology, 64(2), 285-294. Peptide Science, 13(8), 789-806.
22. Hasan, T. H. & Al-Harmoosh, R. A. (2020). 34. Kotian, H. S., Abdulla, A. Z., Hithysini, K. N.,
Mechanisms of Antibiotics Resistance in Bacteria. Harkar, S., Joge, S., Mishra, A., ... & Varma, M. M.

2148| International Journal of Pharmaceutical Research | Jan - Mar 2021 | Vol 13 | Issue 1
Thualfakar Hayder Hasan et al / Proteus Mirabilis Virulence Factors: Review

(2020). Active modulation of surfactant-driven 46. Rutherford, J. C. (2014). The emerging role of
flow instabilities by swarming bacteria. Physical urease as a general microbial virulence
Review E, 101(1), 012407. factor. PLoS Pathog, 10(5), e1004062.
35. Kuan, L., Schaffer, J. N., Zouzias, C. D., & 47. Sarshar, M., Behzadi, P., Ambrosi, C., Zagaglia,
Pearson, M. M. (2014). Characterization of 17 C., Palamara, A. T., & Scribano, D. (2020). FimH
chaperone-usher fimbriae encoded by Proteus and Anti-Adhesive Therapeutics: A Disarming
mirabilis reveals strong conservation. Journal of Strategy Against Uropathogens. Antibiotics, 9(7),
medical microbiology, 63(Pt 7), 911. 397.
36. Liu, M. C., Kuo, K. T., Chien, H. F., Tsai, Y. L., & 48. Schaffer, J. N., & Pearson, M. M. (2017). Proteus
Liaw, S. J. (2015). New aspects of RpoE in mirabilis and urinary tract infections. Urinary
uropathogenic Proteus mirabilis. Infection and Tract Infections: Molecular Pathogenesis and
immunity, 83(3), 966-977. Clinical Management, 383-433.
37. Los, F. C., Randis, T. M., Aroian, R. V., & Ratner, 49. Schneider, R., Lockatell, C. V., Johnson, D., &
A. J. (2013). Role of pore-forming toxins in Belas, R. (2002). Detection and mutation of a
bacterial infectious diseases. Microbiology and luxS-encoded autoinducer in Proteus
Molecular Biology Reviews, 77(2), 173-207. mirabilisThe GenBank accession number for the
38. Majeed, H. T., and Aljanaby, A. A. J. (2019). sequence reported in this paper is
Antibiotic Susceptibility Patterns and Prevalence AY044337. Microbiology, 148(3), 773-782.
of Some Extended Spectrum Beta-Lactamases 50. Simms, A. N., & Mobley, H. L. (2008). Multiple
Genes in GramNegative Bacteria Isolated from genes repress motility in uropathogenic
Patients Infected with Urinary Tract Infections in Escherichia coli constitutively expressing type 1
Al-Najaf City, Iraq. Avicenna journal of medical fimbriae. Journal of bacteriology, 190(10), 3747-
biotechnology, 11(2), 192. 3756.
39. Norsworthy, A. N., & Pearson, M. M. (2017). 51. Stankowska, D., Czerwonka, G., Rozalska, S.,
From catheter to kidney stone: the Grosicka, M., Dziadek, J., & Kaca, W. (2012).
uropathogenic lifestyle of Proteus Influence of quorum sensing signal molecules on
mirabilis. Trends in microbiology, 25(4), 304-315. biofilm formation in Proteus mirabilis O18. Folia
40. Majeed, H.T., Hasan, T.H., Aljanaby, A.A.J.(2020). microbiologica, 57(1), 53-60.
Epidemiological study in women infected with 52. Sun, J., Deering, R. W., Peng, Z., Najia, L., Khoo,
toxoplasma gondii, rubella virus, and cytomegalo C., Cohen, P. S., ... & Rowley, D. C. (2019).
virus in Al-Najaf Governorate-Iraq. International Pectic Oligosaccharides from Cranberry Prevent
Journal of Pharmaceutical Research, 2020, 12, pp. Quiescence and Persistence in the
1442-1447 Uropathogenic Escherichia coli
41. Ostolaza, H., González-Bullón, D., Uribe, K. B., CFT073. Scientific reports, 9(1), 1-9.
Martín, C., Amuategi, J., & Fernandez-Martínez, 53. Tsai, Y. L., Chien, H. F., Huang, K. T., Lin, W. Y.,
X. (2019). Membrane Permeabilization by Pore- & Liaw, S. J. (2017). cAMP receptor protein
Forming RTX Toxins: What Kind of Lesions Do regulates mouse colonization, motility, fimbria-
These Toxins Form?. Toxins, 11(6), 354. mediated adhesion, and stress tolerance in
42. Qiao, G. G., O'Brien-Simpson, N. M., Lam, S. J., uropathogenic Proteus mirabilis. Scientific
& Reynolds, E. C. (2019). U.S. Patent Application reports, 7(1), 1-14.
No. 16/343,556. 54. Wang, W. B., Lai, H. C., Hsueh, P. R., Chiou, R.
43. Ranjbar-Omid, M., Arzanlou, M., Amani, M., Y. Y., Lin, S. B., & Liaw, S. J. (2006). Inhibition of
Shokri Al-Hashem, S. K., Amir Mozafari, N., & swarming and virulence factor expression in
Peeri Doghaheh, H. (2015). Allicin from garlic Proteus mirabilis by resveratrol. Journal of
inhibits the biofilm formation and urease activity medical microbiology, 55(10), 1313-1321.
of Proteus mirabilis in vitro. FEMS microbiology 55. Younis, K. M., Usup, G., & Ahmad, A. (2016).
letters, 362(9), fnv049. Secondary metabolites produced by marine
44. Roh, M. H., Yassin, Y., Miron, A., Mehra, K. K., streptomyces as antibiofilm and quorum-sensing
Mehrad, M., Monte, N. M., ... & Hirsch, M. S. inhibitor of uropathogen Proteus
(2010). High-grade fimbrial-ovarian carcinomas mirabilis. Environmental Science and Pollution
are unified by altered p53, PTEN and PAX2 Research, 23(5), 4756-4767.
expression. Modern Pathology, 23(10), 1316- 56. Zhang, Y., Yang, S., Dai, X., Liu, L., Jiang, X.,
1324. Shao, M., ... & Zhu, R. (2015). Protective
45. Rózalski, A., Sidorczyk, Z., & Koteł ko, K. R. Y. immunity induced by the vaccination of
S. T. Y. N. A. (1997). Potential virulence factors recombinant Proteus mirabilis OmpA expressed
of Proteus bacilli. Microbiology and Molecular in Pichia pastoris. Protein expression and
Biology Reviews, 61(1), 65-89. purification, 105, 33-38.

2149| International Journal of Pharmaceutical Research | Jan - Mar 2021 | Vol 13 | Issue 1

View publication stats

You might also like